跳转至内容
Merck
CN
  • Rationally designing safer anilines: the challenging case of 4-aminobiphenyls.

Rationally designing safer anilines: the challenging case of 4-aminobiphenyls.

Journal of medicinal chemistry (2012-04-06)
Alan M Birch, Sam Groombridge, Robert Law, Andrew G Leach, Christine D Mee, Carolin Schramm
摘要

We describe how we have been able to design 4-aminobiphenyls that are nonmutagenic (inactive in the Ames test). No such 4-aminobiphenyls were known to us, but insights provided by quantum mechanical calculations have permitted us to design and synthesize some examples. Importantly, the quantum mechanical calculations could be combined with predictions of other properties of the compounds that contained the 4-aminobiphenyls so that these remained druglike. Having found compounds that are not active, the calculations can provide insight into which factors (electronic and conformational in this case) are important. The calculations provided SAR-like information that was able guide the design of further examples of 4-aminobiphenyls that are not active in the Ames test.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
4-氨基联苯, ≥98%
Supelco
4-氨基联苯, analytical standard